|
Apr 4
|
Discovering Undiscovered Gems in the US Market April 2025
|
|
Apr 2
|
Could The Market Be Wrong About SIGA Technologies, Inc. (NASDAQ:SIGA) Given Its Attractive Financial Prospects?
|
|
Mar 31
|
Siga Technologies Inc. (SIGA) Stock Sinks As Market Gains: What You Should Know
|
|
Mar 12
|
SIGA Technologies Inc (SIGA) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ...
|
|
Mar 11
|
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024
|
|
Mar 6
|
Undiscovered Gems in the US Market for March 2025
|
|
Mar 6
|
SIGA Technologies (NASDAQ:SIGA) shareholders have endured a 3.0% loss from investing in the stock three years ago
|
|
Mar 4
|
SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results
|
|
Feb 11
|
Siga Technologies Inc. (SIGA) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Jan 3
|
SIGA’s antiviral approved in Japan for orthopoxvirus treatment
|
|
Jan 2
|
Japan Approves SIGA Technologies Antiviral As First For Smallpox, Mpox
|
|
Jan 2
|
TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
|
|
Oct 8
|
SIGA Announces Agreement to Supply TPOXX® in Morocco
|
|
Aug 19
|
WHO declares mpox a public health emergency as variant emerges
|
|
Aug 16
|
NIAID reports preliminary data from trial of SIGA’s Mpox treatment
|
|
Aug 15
|
Top Midday Decliners
|
|
Aug 15
|
Sector Update: Health Care Stocks Rise in Afternoon Trading
|
|
Aug 15
|
Undiscovered Gems In United States To Watch This August 2024
|
|
Aug 15
|
In NIH-Cosponsored Mpox Virus Study In Congo, SIGA Technologies' Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks
|
|
Aug 15
|
Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released
|